Parametric exploration of the liver by magnetic resonance methods

European Radiology

Volumn 19, Issue 11, 2009, Pages 2594-2607

  Sijens, Paul E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Liver; Magnetic resonance imaging; Quantification

Indexed keywords

CARBON 13; FERRITIN; IRON; LIPID; PHOSPHORUS 31;

ARTICLE; ARTIFICIAL EMBOLISM; CARBON NUCLEAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; ELASTOGRAPHY; FAT CONTENT; FERRITIN BLOOD LEVEL; HEPATITIS C; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IRON STORAGE; LIVER BLOOD FLOW; LIVER CANCER; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION; LIVER LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO; STAGING; VISCOELASTICITY;

ANGIOGENESIS INHIBITORS; BIOPSY; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; IRON; LIPIDS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 70350155029     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1470-y     Document Type: Article

References (114)

1. Tian JL, Zhang JS (2006) Hepatic perfusion disorders: Etiopathogenesis and related diseases. World J Gastroenterol 12:3265-3270
2. Lupescu IG, Grasu M, Capşa R, Pitrop A, Georgescu SA (2006) Hepatic perfusion disorders: Computer-tomographic and magnetic resonance imaging. J Gastrointestin Liver Dis 15:273-279
3. Karabulut N, Elmas N (2006) Contrast agents used in MR imaging of the liver. Diagn Interv Radiol 12:22-30
4. Abdullah SS, Pialat JB, Wiart M, Duboeuf F, Mabrut J-Y, Bancel B, Rode A, Ducerf C, Baulieux J, Berthezene Y (2008) Characterization of hepatocellular carcinoma and colorectal liver metastasis by means of perfusion MRI. J Magn Reson Imaging 28:390-395
5. Miyazaki K, Collins DJ, Walker-Samuel S, Taylor JN, Padhani AR, Leach MO, Koh D-M (2008) Quantitative mapping of hepatic perfusion index using MR imaging: A potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor. Eur Radiol 18:1414-1421
6. Hagiwara M, Rusinek H, Lee VS, Lasoda M, Bannan MA, Krinsky GA, Taouli B (2008) Advanced liver fibrosis: Diagnosis with 3D whole-liver perfusion MR imaging - initial experience. Radiology 246:926-934
7. Inoue T, Kudo M, Hatanaka K, Takahashi S, Kitai S, Ueda T, Ishikawa E, Hagiwara S, Minami Y, Chung H, Ueshima K, Maekawa K (2008) Imaging of hepatocellular carcinoma: Qualitative and quantitative analysis of postvascular phase contrast-enhanced untrasonography with Sonazoid. Oncology 75(suppl 1):48-54
8. Finch CA, Bellotti V, Stray S, Lipschitz DA, Cook JD, Pippard MJ, Huebers HA (1986) Plasma ferritin concentration as a diagnostic tool. Clinical review. West J Med 145:657-663
9. Lipschitz DA, Cook JD, Finch CA (1974) A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 290:1213-1216
10. Matzner Y, Konijn AM, Hershko C (1980) Serum ferritin in hematologic malignancies. Am J Hematol 9:13-22
11. Lee MH, Means RT Jr (1995) Extremely elevated serum ferritin levels in a university hospital: Associated diseases and clinical significance. Am J Med 98:566-571
12. Drakoniaki E, Papakonstantinou O, Maris T, Vasiliadou A, Papadakis A, Gourtsoyiannis N (2005) Adrenal glands in beta-thalamassic major: magnetic resonance (MR) imaging features and correlation with iron stores. Eur Radiol 15:2462-2468
13. Kreeftenberg HG Jr., Mooyaart EL, Huizenga JR, Sluiter WJ (2000) Quantification of liver iron concentration with magnetic resonance imaging by combining T1-, T2- weighted spin echo sequences and a gradient echo sequence. Neth J Med 56:133-137
14. St Pierre TG (2005) Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 105:855-8618
15. Argyropoulou MI, Bonkovsky HL (1999) Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. Radiology 212:227-234
16. Bonkovsky HL (1999) Hepatic iron concentration: Noninvasive estimation by means of MR imaging techniques. Radiology 212:227-234
17. Gandon Y, Olivié D, Guyader D, Aubé C, Oberta F, Sebille V, Deugnier Y (2004) Non-invasive assessment of hepatic iron stores by MRI. Lancet 363:357-362
18. Olthof A, Sijens P, Kreeftenberg H, Kappert P, Irwan R, van der Jagt E, Oudkerk M (2007) Correlation between serum ferritin levels and liver iron concentration determined by MR imaging: Impact of hematologic disease and inflammation. Magn Reson Imaging 25:228-231
19. Perifanis V, Christoforidis A, Vlachaki E, Tsatra I, Spanos G, Athanassiou-Metaxa M (2007) Comparison of effects of different long-term iron chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with beta-thalassemia major. Int J Hematol 86:385-389
20. Lam WWM, Au WY, Chu WCW, Tam S, Ha SY, Pennel DJ (2008) One-stop measurement of iron deposition in the anterior pituitary, liver, and heart in thalassemia patients. J Magn Reson Imaging 28:29-33
21. Alustiza JM, Artetxe J, Castiella A, Agirre C, Emparanza JI, Otazua P, Garcia- Bengoechea M, Barrio J, Mujica F, Recondo JA (2004) MR quantification of hepatic iron concentration. Radiology 230:479-484
22. Laine F, Reymann JM, Morel F, Langouet S, Perrin M, Guillygomarc'h A, Brissot P, Turmel V, Mouchel C, Pape D, Bellissant E, Deugnier Y (2006) Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: A randomized trial. Aliment Pharmacol Ther 24:1207-1213
23. Papakonstantinou O, Maris TG, Kostaridou S, Ladis V, Vasiliadou A, Gourtsoyiannis NC (2005) Abdominal lymphadenopathy in beta-thalassemia: MRI features and correlation with liver iron overload and posttransfusion chronic hepatitis C. AJR Am J Roentgenol 185:219-224
24. Olthof AW, Sijens PE, Kreeftenberg HG, Kappert P, van der Jagt E, Oudkerk M (2008) Non-invasive liver iron concentration measurement by MRI: Comparison of two validated protocols. Eur J Radiol. doi: 10.1016/ j.ejrad.2008.02.008
25. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497-505
26. Thoeny HC, De Keyzer F, Boesch C, Hermans R (2004) Diffusion-weighted imaging of the parotid gland: Influence of the choice of b-values on the apparent diffusion coefficient value. J Magn Reson Imaging 20:786-790
27. Yeung DKW, Wong SYS, Griffith JF, Lau EMC (2004) Bone marrow diffusion in osteoporosis: Evaluation with quantitative MR diffusion imaging. J Magn Reson Imaging 19:222-228
28. Luciani A, Vignaud A, Cavet M, Van Nhieu JT, Mallat A, Ruel L, Laurent A, Deux JF, Brugieres P, Rahmouni A (2008) Liver cirrhosis: intravoxel incoherent motion MR imaging. Radiology 249:891-899
29. Goshima S, Kanematsu M, Kondo H, Yokoyama R, Kajita K, Tsuge Y, Watanabe H, Shiratori Y, Onezuka M, Moriyama N (2008) Diffusion-weighted imaging of the liver: Optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging 28:691-697
30. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H (1999) Diffusion coefficients in abdominal organs and hepatic lesions: Evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 219:617-623
31. Koh DM, Scurr E, Collins DJ, Pirgon A, Kanber B, Karanjia N, Brown G, Leach MO, Husband JE (2006) Colorectal hepatic metastases: Quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging. Eur Radiol 16:1898-1905
32. Sun XJ, Quan XY, Huang FH, Xu YK (2005) Quantitative evaluation of diffusion-weighted magnetic resonance imaging of focal hepatic lesions. World J Gastroenterol 11:6535-6537
33. Bruegel M, Holzapfel K, Gaa J, Woertler K, Waldt S, Kiefer B, Stemmer A, Ganter C, Rummeny EJ (2008) Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 18:477-485
34. Inan N, Arslan A, Akansel G, Anik Y, Sarisoy TH, Ciftci E, Dimerci A (2007) Diffusion-weighted imaging in the differential diagnosis of simple and hydatid cysts of the liver. AJR Am J Roentgenol 189:1031-1036
35. Girometti R, Furlan A, Esposito G, Bazzocchi M, Como G, Soldano F, Isola M, Toniutto P, Zuiani C (2008) Relevance of b-values in evaluating liver fibrosis: A study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences. J Magn Reson Imaging 28:411-419
36. Kwee TC, Takahara T, Koh DM, Nievelstein RA, Kuijten PR (2008) Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free breathing diffusion-weighted MR imaging of the liver. J Magn Reson Imaging 28:1141-1148
37. Chen YC, Li CW, Kuo YT, Jaw TS, Wu DK, Jao JC, Hsu JS, Liu GC (2006) Early response of hepatocellular carcinoma to transcatheter arterial chemoembolisation: Choline levels and MR diffusion constants - initial experience. Radiology 239:448-456
38. Kamel IR, Liapi E, Reyes DK, Zuhurak M, Bleumke DA, Geschwind JFH (2009) Unresectable hepatocellular carcinoma: Serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology 250:466-473
39. Gourtsoyianni S, Papanicolaou N, Yarmenitis S, Maris T, Karantanas A, Gourtsoyiannis N (2008) Respiratory gated diffusion weighted imaging of the liver: Value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 18:486-492
40. Hoolingsworth KG, Lomas DJ (2006) Influence of perfusion on hepatic MR diffusion measurement. NMR Biomed 19:231-235
41. Parker KJ, Huang SR, Musulin RA, Lerner RM (1990) Tissue response to mechanical vibration s for sonoelasticity imaging. Ultrasound Med Biol 16:241-246
42. Muthupillai R, Lomas DJ, Rossman PJ, Greenleaf JF, Manduca A, Ehman RL (1995) Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 269:1854-1857
43. Plewes DB, Betty I, Urchuk SN, Soutar I (1995) Visualizing tissue compliance with MR imaging. J Magn Reson imaging 5:733-738
44. Rouvière O, Yin M, Dresner MA, Rossman PJ, Burgart LJ, Fidler JL, Ehman RL (2006) MR elasticity of the liver: Preliminary results. Radiology 240:440-448
45. Huwart L, Peeters F, Sinkus R, Annet L, Salameh N, ter Beek LC, Horsmans Y, Van Beers BE (2006) Liver fibrosis: Non-invasive assessment with MR elastography. NMR Biomed 19:173-179
46. Klatt D, Asbach P, Rump J, Papazoglou S, Somasundaram M, Modrow J, Braun J, Sack I (2006) In vivo determination of hepatic stiffness using steady-state free precession magnetic resonance elastography. Invest Radiol 41:841-848
47. Yin M, Woollard J, Wang X, Torres VE, Harris PC, Ward CJ, Glaser KJ, Manduca A, Ehman RL (2007) Quantitative assessment of hepatic fibrosis in an animal model with magnetic resonance elastography. Magn Reson Med 58:346-353
48. Klatt D, Hamhaber U, Asbach P, Braun J, Sack I (2007) Noninvasive assessment of the rheological behavior of human organs using multifrequency MR elastography: A study of brain and liver viscoelasticity. Phys Med Biol 52:7281-7294
49. Salameh N, Peeters F, Sinkus R, Abarca-Quinones J, Annet L, ter Beek LC, Leclercq I, Van Beers BE (2007) Hepatic viscoelastic parameters measured with MR elastography: Correlations with quantitative analysis of liver fibrosis in the rat. J Magn Reson Imaging 26:956-962
50. Rump J, Klatt D, Braun J, Warmuth C, Sack I (2007) Fractional encoding of harmonic motions in MR elastography. Magn Reson Med 57:388-395
51. Asbach P, Klatt D, Hamhaber U, Braun J, Somasundaram R, Hamm B, Sack I (2008) Assessment of liver viscoelasticity using multifrequency MR elastography. Magn Reson Med 60:373-379
52. Huwart L, Sempoux C, Salameh N, Jamart J, Annet L, Sinkus R, Peeters F, ter Beek LC, Horsmans Y, Van Beers BE (2007) Liver fibrosis: non-invasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 245:458-466
53. Yin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, Fidler JL, Ehman RL (2007) A preliminary assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5:1207-1213
54. Venkatesh SK, Yin M, Glockner JF, Takahashi N, Araoz PA, Talwalkar JA, Ehman RL (2008) MR elastography of liver tumors: Preliminary results. Am J Roentgenol AJR 190:1534-1540
55. Bonekamp S, Kamel I, Solga S, Clark J (2009) Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatology 50:17-35
56. Adams LA, Sanderson S, Lindor KD, Angulo P (2005) The histological course of nonalcoholic fatty liver disease: A longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 42:132-138
57. Dam-Larsen S, Franzmann MB, Christoffersen P, Larsen K, Becker U, Bendtsen F (2005) Histological characteristics and prognosis in patients with fatty liver. Scand J Gastroenterol 40:460-467
58. Hoyumpa AM Jr, Green HL, Dunn GD, Schenker S (1975) Fatty liver: biochemical and clinical considerations. Am J Dig Dis 20:1142-1170
59. Volzke H, Robinson DM, Kleine V, Deutcher R, Hoffmann W, Ludeman W, Schminke U, Kessler C, John U (2005) Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 11:1848-1853
60. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH (2004) Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 40:1387-1395
61. Szczepaniak LS, Nurenberg P, Leonard D, browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:E462-E468
62. Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G (2004) Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: Role of visceral fat accumulation. Diabetes Care 27:2498-2500
63. Kim SH, Lee JM, Han JK, Lee JY, Lee KH, Han CJ, Jo JY, Yi NJ, Suh KS, Shin KS, Jo SY, Choi BI (2006) Hepatic macrosteatosis: Predicting appropriateness of liver donation by using MR imaging - correlation with histopathologic findings. Radiology 240:117-129
64. Valls C, Iannacconne R, Alba E, Murakami T, Hori M, Passariello R, Vilgrain V (2006) Fat in the liver: Diagnosis and characterization. Eur Radiol 16:2292-2308
65. 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 4:297-302
66. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O (1994) Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12:487-495
67. 1H MR spectroscopy of phosphorylase-b kinase deficient patients (GSD IXa) showing an accumulation of fat in the liver that resolves with aging. J Hepatol 45:851-855
68. Irwan R, Edens MA, Sijens PE (2008) Assessment of the variations in fat content in normal liver using a fast quantification MR imaging method in comparison with results obtained by spectroscopic imaging. Eur Radiol 18:806-813
69. Johnson NA, Walton DW, Sachinwalla T, Thompson CH, Smith K, Ruell PA, Stannard SR, George J (2008) Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders. Hepatology 47:1513-1523
70. Dixon WT (1984) Simple proton spectroscopic imaging. Radiology 153:189-194
71. Hussain HK, Chenevert TL, Londy FJ, Gulani V, Swanson SD, McKenna BJ, Appelman HD, Adusumilli S, Greenson JK, Conjeevaram HS (2005) Hepatic fat fraction: MR imaging for quantitative measurement and display - early experience. Radiology 237:1048-1055
72. O'Regan DP, Callaghan MF, Wylezinska-Arridge M, Fitzpatrick J, Naoumova RP, Hajnal JV, Schmitz SA (2008) Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T - feasibility. Radiology 247:550-557
73. Guiu B, Loffroy R, Cercueil JP, Krause D (2008) Multiecho MR imaging and proton MR spectroscopy for liver fat quantification (letter-to-the-editor). Radiology 249:1081
74. Xiang QS (2006) Two-point water-fat imaging with partially opposed-phase (POP) acquisition: An asymmetric Dixon method. Magn Reson Med 56:572-584
75. Paltiel Z (1985) Separate water and lipids images obtained by a single scan. In: Proceedings of the 4th Annual Meeting of SMRM, New York, USA, pp 172-173
76. Patrick JL, Haacke EM, Hahn JE (1985) Water fat separation and chemical shift artefact correction using a single scan. In: Proceedings of the 4th Annual Meeting of SMRM, New York, USA, pp 174-175
77. Ahn CB, Lee SY, Nalcioglu O, Cho ZH (1986) Spectroscopic imaging by quadrature modulated echo time shifting. Magn Reson Imaging 4:110-111
78. Xiang QS, An L (1997) Water-fat imaging with direct phase encoding. J Magn Reson Imaging 7:1002-1015
79. Cottler SJ, Guzman G, Layden-Almer J, Mazzone T, Layden TJ, Zhou XJ (2007) Measurement of liver fat content using selective saturation at 3.0 T. J Magn Reson Imaging 25:743-748
80. 1H-MR spectroscopy. Magn Reson Med 55:913-917
81. Sijens PE, Oudkerk M (2005) Clinical magnetic resonance spectroscopy. Imaging Decis MRI 9:39-48
82. Sijens PE, Dagnelie PC, Halfwerk S, van Dijk P, Wicklow K, Oudkerk M (1998) Understanding the discrepancies between 31P MR spectroscopy assessed liver metabolite concentrations from different institutions. Magn Reson Imaging 16:205-211
83. 31P MRS in vivo. Magn Reson Med 32:453-458
84. Norén B, Lundberg P, Ressner M, Wirell S, Almer S, Smedby O (2005) Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease. Eur Radiol 15:148-157
85. Cox IJ, Couts GA, Gadian DG, Ghosh P, Sargentoni J, Young IR (1991) Saturation effects in phosphorus-31 magnetic resonance spectra of the human liver. Magn Reson Med 17:53-61
86. Sijens PE, van Dijk P, Dagnelie PC, Oudkerk M (1995) Non-T1 weighted 31P MR chemical shift imaging of the human liver. Magn Reson Imaging 13:621-628
87. 31P NMR spectra localized by three-dimensional chemical shift imaging. NMR Biomed 9:141-155
88. 31P magnetic resonance spectroscopy. J Hepatol 42:752-759
89. Menon DK, Sargentoni J, Taylor-Robinson SD, Bell JD, Cox IJ, Bryant DJ, Coutts GA, Rolles K, Burroughs AK, Morgan MY (1995) Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: Biochemical basis of spectral appearances. Hepatology 21:417-427
90. 31P magnetic resonance spectroscopy of the liver: Correlation with standardized serum, clinical, and histological changes in diffuse liver disease. Hepatology 21:443-449
91. 31P MR spectroscopy. World J Gastroenterol 11:6926-6931
92. Lim AKP, Patel N, Hamilton G, Mylvahan K, Kuo Y-T, Goldin RD, Taylor-Robinson SD (2007) 31P MR spectroscopy in assessment of response to antiviral therapy for hepatitis C virus-related liver disease. Am J Roentgenol AJR 189:819-823
93. Norén B, Dahlquist O, Lundberg P, Almer S, Kechagias S, Ekstedt M, Franzèn L, Wirell S, Smedby O (2008) Separation of advanced from mild cirrhosis in diffuse liver disease using 31P magnetic resonance spectroscopy. Eur Radiol 15:148-157
94. Lim AKP, Patel N, Hamilton G, Goldin RD, Hajnal JV, Taylor-Robinson SD (2003) Findings at 31P magnetic resonance spectroscopy correlate with histology in chronic hepatitis C virus infection. Hepatology 27:788-794
95. 31P) phosphorus magnetic resonance spectroscopy. Atherosclerosis 203(1):291-297. doi: 10.1016/ j.atherosclerosis.2008.06.016
96. 31P MR spectroscopy. NMR Biomed 12:535-544
97. Leij-Halfwerk S, Dagnelie PC, Kappert P, Oudkerk M, Sijens PE (2000) Decreased hepatic energy and phosphorylation status in the liver of advanced lung cancer patients with weight loss. J Hepatol 32:887-892
98. 31P spectroscopy using the magnetization transfer experiment. NMR Biomed 21:437-443
99. Jiang T, Liu S, Xiao XS, Toa XF, Liu GH, Wang JL (2008) Diagnosis of rejection after liver transplantation: Use of phosphorus-31 magnetic resonance spectroscopy. Abdom Imaging. doi: 10.1007/s00261-008-9451-1
100. 1H-MR spectroscopy. AJR Am J Roentgenol 190:1331-1339
101. 13C magnetic resonance spectroscopy. Magn Reson Imaging 14:1217-1220
102. Tomiyasu M, Obata T, Nishi Y, Nakamoto H, Nonaka H, Takayama Y, Autio J, Ikehira H, Kanno I (2009) Monitoring of liver glycogen synthesis in diabetic patients using carbon-13 MR spectroscopy. Eur J Radiol. doi: 10.1016/j.ejrad.2008.10.019
103. Wolf W, Albright MJ, Silver MS, Weber H, Reichart U, Sauer R (1987) Fluorine-19 NMR spectroscopic studies of the metabolism of patients undergoing chemotherapy. Magn Reson Imaging 5:165-169
104. 19F magnetic resonance spectroscopy. Clin Cancer Res 2:339-345
105. Semmler W, Bachert-Bauman P, Gückel F, Ermark F, Schlag P, Lorenz WJ, van Kaick G (1990) Real-time follow-up of 5-fluorouracil in the liver of tumor patients by means of F-19 MR spectroscopy. Radiology 174:141-145
106. 19F MRS pharmacokinetic studies of 5-fluorouracil. NMR Biomed 20:128-140
107. 31P magnetic resonance spectroscopy. Pediatr Res 36:436-440
108. Dufour JF, Stoupis C, Lazeyras F, Vock P, Terrier F, Reichen J (1992) Alterations in hepatic fructose metabolism in cirrhotic patients demonstrated by dynamic 31 phosphorus spectroscopy. Hepatology 15:835-842
109. 31P magnetic resonance spectroscopy in vivo. Clin Sci 98:167-174
110. 31P MR spectroscopy and turnover measurements. Cancer Res 60:618-623
111. 31P magnetic resonance spectroscopy study. Hepatology 35:421-424
112. 31P NMR spectroscopy in vivo and in vitro. NMR Biomed 6:157-162
113. Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC (2004) In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging 19:598-604
114. Soper R, Himmelreich U, Painter D, Somorjai RL, Lean CL, Dolenko B, Mountford CE, Russell P (2002) Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy. Pathology 34:417-422